Connect with us

Entertainment

Kristen Doute Addresses Raquel’s Claims She Took ‘Hush Money’ From Bravo on August 18, 2023 at 12:58 pm Us Weekly

Published

on

Kristen Doute and Raquel Leviss Getty Images (2)
Kristen Doute is sharing her side of the story after Raquel Leviss made claims about the upcoming Vanderpump Rules spinoff.
“Rachel is not lying in the small clip that I heard … she’s telling some truths,” Doute said via Instagram Stories on Thursday, August 17. “But I was definitely not offered any sort of hush money or anything like that.”
Earlier on Thursday, Leviss alleged that Doute was cast on Bravo’s new series as a way to stop Doute from speaking out against their mutual ex, James Kennedy.
“Kristen was just starting to talk about her tumultuous relationship with James and what happened behind closed doors. Then all of a sudden she’s presented with this spinoff,” Leviss told Bethenny Frankel on her iHeartRadio podcast. “I believe [it] is a way to silence her — to keep that under wraps — so that the longevity of Vanderpump Rules can continue. … I’ve seen him be a violent person so I have no doubt that what she’s saying is true. I hope that one day it will come to light and there will be justice.”

‘Vanderpump Rules’ Stars Who Left the Series: Where Are They Now?

Read article

Doute, who got physical with Kennedy during season 3 of Vanderpump Rules, later returned to the platform twice to attempt to clarify her statement.

“I have not listened to Bethenny’s podcast with Rachel. I saw a TikTok that had a clip that had my name in it, so that is what I was responding to. And I’m now hearing all sorts of things that were also said, [that] I have no idea [about],” Doute said. “I agree with what Rachel says about you know who — I think I’ve made my feelings very clear. But also you guys, for realsies, there’s no opportunity, no new anything, that I was given, like, to silence me or as hush money or anything like that. So that part is completely incorrect. And I hope that clears things up.”
James Kennedy attends the 2022 MTV Movie & TV Awards: UNSCRIPTED at Barker Hangar in Santa Monica, California and broadcast on June 5, 2022. Rich Polk/Getty Images for MTV
A spokesperson for Bravo also denied Leviss’ claims, telling Us Weekly in a statement: “Kristen Doute was one of the people approached for an upcoming spinoff because she is part of the friend group that is featured on a new show.”
The network subsequently contested Leviss’ remarks about Tom Sandoval’s negotiations for season 11. (Leviss and Sandoval were under fire at the end of season 10 when their months-long affair behind his then-girlfriend Ariana Madix’s back was exposed.)
“I don’t know if I’m even able to disclose this information, but he did tell me during negotiations for season 11 that he was offered a producer credit for season 11,” Leviss told Frankel. “It makes me skeptical, like, was this really just something that was fabricated for this end result.”
She went on to claim that Sandoval convinced producers to cut a line about the NSFW FaceTime he recorded of Leviss.
“When Tom and I were filming at my apartment, after filming got picked back up, I said to Tom, ‘How can I trust you? You filmed me without my consent.’ And he admitted to it. But then after that scene wrapped, he said, ‘Why did you say that? Why did you say that on camera? You made me look bad,’” Leviss alleged. “And I was like, ‘Well, because that’s what happened.’ … He ended up boycotting filming the rest of Scandoval so that he could have editing rights to that scene to take out that specific [scene].”
Bravo told Us in response: “Tom Sandoval was never offered a producer credit on season 11, and had absolutely no creative control over any editing during any season of Vanderpump Rules.”

Kristen Doute is sharing her side of the story after Raquel Leviss made claims about the upcoming Vanderpump Rules spinoff. “Rachel is not lying in the small clip that I heard … she’s telling some truths,” Doute said via Instagram Stories on Thursday, August 17. “But I was definitely not offered any sort of hush 

​   Us Weekly Read More 

Advertisement
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advice

Independent Film’s New Reality: 10 Brutal Truths You Have to Face in 2026

Published

on


If you are still approaching independent film like it’s 2015, you are going to get crushed. The landscape that once rewarded a scrappy feature and a couple of festival laurels has become a crowded, algorithm‑driven marketplace where attention is the rarest currency. Recent industry analysis on “inflection points” for 2026 all say the same thing: the business model for independent film has changed, whether you like it or not.

1. You’re Competing With Everything

Your film is no longer just competing with other indie features. It is fighting for attention against TikTok clips, prestige series, and endless back catalog on every streaming platform. That means “pretty good” is invisible. You either have a sharp, specific audience and a clean logline, or you disappear into the scroll.

2. Festivals Are Not a Distribution Plan

A festival premiere and a few Q&As can help with credibility, but they are not a business strategy. Without a parallel plan—email list, community building, partnerships, and a clear path to paid viewers—you come home with a laurel and no deal. Even festival‑aligned organizations now frame their “don’t miss indies” coverage as part of a broader visibility and audience strategy, not a finish line.

3. The Middle Is Collapsing

Industry voices are blunt about it: micro‑budget genre films and clearly branded auteur work still find lanes, but the soft, mid‑budget drama with no hook is almost impossible to monetize. If your film cannot be pitched in one or two sentences to a specific audience, it will struggle regardless of how “good” it is.

4. You Are a Small Business, Not a Starving Artist

The indie filmmakers who will survive 2026 are treating their careers like businesses. Guides focused on creating a “film business turnaround” talk about lifetime value, repeat customers, multiple revenue streams, and audience retention—not just finishing one feature. Your filmography is a product line, not a lottery ticket.

Advertisement

5. SAG Is a Competitive Advantage

SAG actors and union rules are not your enemy; they are a way to level up. SAGindie and SAG‑AFTRA low‑budget agreements exist to help genuine independents hire professional talent and present themselves as serious, compliant productions. Understanding those tools gives you access to stronger cast, better reputations, and more credible pitches.

6. Streaming Is Not a Golden Ticket

Streaming is no longer the dream “one deal solves everything” outcome. The deals are leaner, the competition is brutal, and many filmmakers now make more by going direct‑to‑fan through TVOD, memberships, or niche platforms than by chasing a low‑MG all‑rights license. You need to know why you want a streamer—brand value, audience reach, or pure revenue—and plan accordingly.

7. Format Matters Less Than Relationship

Audiences care more about access than whether your project is a feature, series, or hybrid. If you give them a reason to show up repeatedly, they will follow you across formats. If you do not, a 90‑minute feature is just one more piece of content in an endless feed.elliotgrove.

8. Marketing Starts at Concept

Marketing is not something you “figure out later.” The most effective 2026 indies build their hook at the idea stage—title, poster, and logline are treated as core creative decisions, not afterthoughts. If you cannot imagine the trailer, one‑sheet, and social teaser while you are still outlining, that is a red flag.

9. Community Is Your Real Safety Net

Filmmakers who plug into networks, reading lists, and producer education hubs are adapting the fastest. They are not reinventing the wheel alone; they are leveraging shared knowledge, updated contracts, and peer feedback to make smarter decisions project by project.

10. Accepting Reality Is Your Edge

Here is the real brutal truth: if you can accept all of this, you gain an edge. Most of the field is still clinging to old myths about discovery, “overnight” success, and festival miracles. If you are willing to treat your indie career as a living, evolving business—grounded in current data and audience behavior—2026 might be the moment where “truly independent” stops meaning powerless and starts meaning in control.

Advertisement

Continue Reading

Entertainment

Ozempic Era: Beauty, Lizard Venom, Big Pharma

Published

on

The film industry is entering a new body era, and this time, the co-star is a syringe.

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have moved from diabetes clinics into casting conversations, red carpets, and agency strategy. In the United States, roughly 1 in 8 adults report having used a GLP-1 drug, with about 6 to 12 percent actively using one today. Globally, usage has surged from approximately 4 million people in 2020 to around 30 million by 2026.

This is no longer a niche health trend. It is a structural shift—one that is reshaping how bodies are constructed, perceived, and rewarded on screen.

At a clinical level, the appeal is clear. In major obesity trials, semaglutide has produced average weight loss of 15 to 17 percent of total body weight over 68 to 104 weeks, with some regimens approaching 19 to 21 percent for sustained users. In an industry built on transformation, those numbers carry real influence.

But rapid transformation leaves a visible trace. The phenomenon often called “Ozempic face”—hollowed cheeks, looser skin, a subtly aged appearance—reflects how quickly fat loss can outpace the skin’s ability to adjust.

Advertisement

For filmmakers, this is not just aesthetic—it is cinematic. Performance lives in the face. Micro-expressions, softness, and facial volume shape how emotion reads on camera. A performer may reach an “ideal” body while losing something less measurable but equally important on screen.

Beneath this cultural shift lies an origin story that feels almost written for film.

In the 1990s, researchers studying the Gila monster isolated a peptide in its venom called exendin-4, which mimicked a human hormone involved in blood sugar regulation but lasted significantly longer in the body. That discovery led to early GLP-1 drugs such as exenatide, used by millions of patients worldwide, and eventually to semaglutide.

By mid-2025, semaglutide-based drugs (including Ozempic and Wegovy) generated approximately $16 to $17 billion in just six months, making it one of the highest-grossing drug classes globally. Analysts project the broader incretin market could reach $200 billion annually by 2030.

Advertisement
HCFF
HCFF

Inside those numbers is a more complex human story.

The benefits are well documented: improved blood sugar control, significant weight loss, and reduced cardiovascular risk. But as use expands, so does scrutiny. Researchers and regulators are tracking side effects ranging from severe gastrointestinal issues and gastroparesis to gallbladder disease and pancreatitis, as well as rarer concerns such as vision complications and potential neurological signals.

At the same time, adoption continues to accelerate. J.P. Morgan projects roughly 10 million Americans on GLP-1 drugs by 2025, rising toward 25 to 30 million by 2030. At that scale, usage becomes ambient—part of everyday life across industries, including film and television.

And yet the marketing tells a different story. Pharmaceutical campaigns rely on cinematic language—aspirational visuals, controlled lighting, emotional transformation arcs—while legally required risk disclosures recede into fine print.

For independent filmmakers, this moment opens several narrative lanes.

Advertisement

There is the body: performers navigating an industry where a once-niche diabetes drug has become a quiet career tool.

There is the machine: a pharmaceutical ecosystem where a single drug category generates tens of billions annually, rivaling major entertainment sectors.

And there is the myth: a culture increasingly turning to a hormone-based intervention—derived from venom biology—rather than addressing systemic issues like food access, stress, and inequality.

Advertisement

Technology intensifies all of it. Ultra-high-resolution cameras and HDR workflows capture every detail—skin texture, volume shifts, micro-expressions. As more on-screen talent uses the same class of drugs, a new visual baseline begins to form, often without audiences realizing why.

There is also a clear economic divide. GLP-1 drugs can cost $800 to $1,000 or more per month without insurance in the United States, and coverage remains inconsistent. Rising demand has led to shortages and a parallel market of compounded or unregulated alternatives.

The gap between who can access consistent, medically supervised treatment and who cannot is becoming part of the story itself.

For cinema, the imagery is already there: the Sonoran desert, a Gila monster, laboratory research, pharmaceutical earnings calls, red carpets, and transformation narratives.

A compound derived from venom becomes a global product that reshapes not only bodies, but expectations.

Advertisement

Perhaps the most uncomfortable layer is the industry’s own role. Casting preferences, transformation culture, and unspoken aesthetic standards reinforce a pharmacological look without ever naming it.

No one explicitly instructs performers to take these drugs. The system simply rewards the results.

This is not a distant trend. It is a present-tense shift.

The numbers are rising. The images are changing. The influence is expanding.

Advertisement

The question is whether independent cinema will define this moment while it is still unfolding—or whether the story will once again be shaped by the industries profiting most from it.

Continue Reading

Advice

How to Find Your Voice as a Filmmaker

Published

on

Every filmmaker aspires to create projects that are not only memorable but also uniquely their own. Finding your creative voice is a journey that requires self-reflection, bold choices, and an unwavering commitment to your vision. Here’s how to uncover your style, take risks, and craft original work that stands out.

1. Discovering Your Voice: Understanding Your Influences

Your unique voice begins with recognizing what inspires you.

  • Step 1: Reflect on the themes, genres, or emotions that consistently draw your interest. Are you inspired by human resilience, surreal worlds, or untold histories?
  • Step 2: Study the work of filmmakers you admire. Analyze what resonates with you—their use of color, pacing, or narrative techniques.

Tip: Combine what you love with your personal experiences to create a lens that only you can offer.

Example: Wes Anderson’s whimsical, symmetrical worlds stem from his love of classic storytelling and his unique visual style.

HCFF

Takeaway: Start with what moves you, then add your personal touch.

2. Taking Creative Risks: Experiment and Evolve

To stand out, you must be willing to challenge conventions and explore new territory.

Example: Jordan Peele blended horror with social commentary in Get Out, creating a genre-defying film that captivated audiences.

Takeaway: Risks are an opportunity for growth, even if they don’t always succeed.

Advertisement

3. Telling Original Stories: Start with Authenticity

Original projects resonate when they stem from a place of truth.

  • Draw from Experience: Incorporate elements of your own life, culture, or worldview into your stories.
  • Explore the “Why”: Ask yourself why this story matters to you and how it connects with your audience.
  • Avoid Trends: Focus on timeless narratives rather than chasing current fads.

Example: Greta Gerwig’s Lady Bird was deeply personal, based on her experiences growing up in Sacramento. The film’s authenticity made it universally relatable.

Takeaway: The more personal the story, the more it resonates.

4. Developing Your Style: Consistency Meets Creativity

Style is not just about visuals—it’s how you tell a story across all elements of filmmaking.

  • Visual Language: Experiment with colors, lighting, and framing to create a distinct aesthetic.
  • Narrative Voice: Develop consistent themes or motifs across your projects.
  • Sound Design: Use music, sound effects, and silence to evoke specific emotions.

Example: Quentin Tarantino’s use of dialogue, pop culture references, and bold music choices makes his work instantly recognizable.

Takeaway: Your style should be intentional, evolving as you grow but always recognizable as yours.

5. Staying True to Yourself: Building Confidence in Your Vision

The filmmaking process is full of challenges, but staying true to your voice is essential.

Advertisement
  • Stay Authentic: Trust your instincts, even if your ideas seem unconventional.
  • Adapt Without Compromise: Be open to feedback but maintain your core vision.
  • Celebrate Your Growth: View every project, successful or not, as a stepping stone in your creative journey.

Example: Ava DuVernay shifted from public relations to filmmaking, staying true to her voice in films like Selma and 13th, which focus on social justice.

Takeaway: Your voice evolves with every project, so embrace the process.

Conclusion: From Idea to Screen, Your Voice is Your Superpower

Finding your voice as a filmmaker takes time, courage, and commitment. By exploring your influences, taking risks, and staying true to your perspective, you’ll craft stories that not only stand out but also resonate deeply with your audience.

Bolanle Media is excited to announce our partnership with The Newbie Film Academy to offer comprehensive courses designed specifically for aspiring screenwriters. Whether you’re just starting out or looking to enhance your skills, our resources will provide you with the tools and knowledge needed to succeed in the competitive world of screenwriting. Join us today to unlock your creative potential and take your first steps toward crafting compelling stories that resonate with audiences. Let’s turn your ideas into impactful scripts together!

Advertisement
Continue Reading

Trending